← All indications
Basal Cell Nevus Syndrome
Hereditary disorder consisting of multiple basal cell carcinomas, odontogenic keratocysts, and multiple skeletal defects, e.g., frontal and temporoparietal bossing, bifurcated and splayed ribs, kyphoscoliosis, fusion of vertebrae, and cervicothoracic spina bifida. Genetic transmission is autosomal dominant.
Drugs by status
Phase 3 trials (3)
Phase 2 trials (11)
Phase 1 trials (1)
Other trials (2)
Organizations
Organization Involved with Phase 3 Indications (3)
Organization Involved with Phase 2 Indications (15)
- Roche
- Genentech
- Stamford Pharmaceuticals
- Inhibitor Therapeutics
- National Cancer Institute (NCI)
- Herbert Irving Comprehensive Cancer Center
- Oregon Health and Science University
- University of Manchester
- Columbia University
- University of California, San Francisco
- Sinclair Dermatology Pty Ltd
- Siller Medical T/A Central Brisbane Dermatology
- Veracity Clinical Research
- Ameriderm Research
- Central Brisbane Dermatology
Organization Involved with Phase 1 Indications (4)
Organization Involved with Other Experimental Indications (5)